跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Cibinqo - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Cibinqo
Approved
STANDARD
Cibinqo
Pfizer Manufacturing Deutschland GmbH
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
70929303acaafe2f
Company
Pfizer Manufacturing Deutschland GmbH
Type
Standard
Approval Details
Approval Id
70929303acaafe2f
Drug Approval Philippines Name
Cibinqo
Product Name
Cibinqo
Registration Number
DR-XY48137
Brand Name
Cibinqo
Generic Name
Abrocitinib
Dosage Form
Film-coated Tablet
Dosage Strength
100 mg
Manufacturer
Pfizer Manufacturing Deutschland GmbH
Importer
Pfizer, Inc.
Company Detail Path
/organization/pfizer-manufacturing-deutschland-gmbh
Importer Detail Path
/organization/pfizer-inc-pleasant-prairie-wisconsin-united-states
Issuance Date
27 June 2022
Expiry Date
27 June 2027
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
70929303acaafe2f
Type
Standard
Back to Philippines FDA Approvals